Earlier today, 29 members of the MAPRx Coalition sent a letter to Congressional leaders urging them to establish an out-of-pocket (OOP) cap for Medicare Part D to limit the amount Medicare beneficiaries have to pay for covered prescription drugs.
The Coalition continues to believe that the lack of an OOP cap is one of the biggest... Read more
Earlier today, the MAPRx Coalition hosted a virtual briefing for members of Congress, their staff, and MAPRx member organizations.
After Corey Ford of Xcenda provided an overview of the Medicare Part D benefit, Illy Jaffer of the American Cancer Society Cancer Action Network and Bari Talente of the National Multiple Sclerosis Society spoke to the costs... Read more
Earlier today, the MAPRx Coalition and 27 of its member organizations submitted letters to House and Senate leadership in response to the ongoing congressional efforts to address drug pricing and affordability.
Specifically, the letters urged congressional leaders to focus on the following policies to improve the beneficiary experience... Read more
Earlier today, the MAPRx Coalition and 38 health advocacy organizations sent a letter to Health and Human Services (HHS) Secretary Designee Xavier Becerra in opposition to recent proposed changes to Medicare Part D, including the longstanding six protected classes policy.
The changes, announced on January 19 in the final days of the previous... Read more
The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2020 – December 7, 2020 for coverage beginning January 1, 2021. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole may also impact how beneficiaries move through... Read more
We are eager to hear about your experiences with the Medicare prescription drug program. We would like to hear about both good and bad experiences that you have had selecting and signing up for a plan, getting your drugs, and paying for your drugs. The form below will allow you to write your story.
Thank you for taking the time to tell us your story.